Citation Impact
Citing Papers
New frontiers in liver resection for hepatocellular carcinoma
2020
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations
2008
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Hepatocellular carcinoma
2016 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Hepatitis C virus and microRNAs: miRed in a host of possibilities
2014
Chronic hepatitis B: Update 2009 #
2009 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
2023 Standout
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
2015
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies
2015
Natural history of hepatitis C
2014
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Hepatocellular carcinoma
2022 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection
2017
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
2016
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
2023
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
The impact of hepatitis C burden: an evidence‐based approach
2014
Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells
2013
Works of Barbara Guerrera being referenced
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti‐hepatitis B e‐positive chronic hepatitis
2005
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience
2019
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
2012
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations
2013
Chronic HCV infection is a risk factor of ischemic stroke
2013